Stay updated on Pembrolizumab and Lenvatinib in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Lenvatinib in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Lenvatinib in Melanoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Updates the Chile location listing to use shorter region labels (e.g., Araucania and Valparaiso) alongside the corresponding city/state entries, and updates the displayed site revision version.
    Difference
    0.4%
    Check dated 2026-04-24T05:44:21.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:17:38.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Added Padova, Italy, 35128 as a study location and removed Padua, Italy, 35128.
    Difference
    0.0%
    Check dated 2026-04-09T20:34:31.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The Italian trial site entry was updated from Napoli, Italy, 80131 to Naples, Italy, 80131.
    Difference
    0.0%
    Check dated 2026-03-26T04:15:08.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Added revision tag v3.5.0 and removed revision tag v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T21:00:12.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.4.2 to v3.4.3. No user-facing content or functionality changes.
    Difference
    0.0%
    Check dated 2026-03-11T20:02:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Lenvatinib in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Lenvatinib in Melanoma Clinical Trial page.